000118992 001__ 118992
000118992 005__ 20230519145626.0
000118992 0247_ $$2doi$$a10.1007/s00228-021-03101-4
000118992 0248_ $$2sideral$$a129435
000118992 037__ $$aART-2021-129435
000118992 041__ $$aeng
000118992 100__ $$aBakkum, Michiel J.
000118992 245__ $$aEurOP2E – the European Open Platform for Prescribing Education, a consensus study among clinical pharmacology and therapeutics teachers
000118992 260__ $$c2021
000118992 5060_ $$aAccess copy available to the general public$$fUnrestricted
000118992 5203_ $$aPurpose
Sharing and developing digital educational resources and open educational resources has been proposed as a way to harmonize and improve clinical pharmacology and therapeutics (CPT) education in European medical schools. Previous research, however, has shown that there are barriers to the adoption and implementation of open educational resources. The aim of this study was to determine perceived opportunities and barriers to the use and creation of open educational resources among European CPT teachers and possible solutions for these barriers.
Methods
CPT teachers of British and EU medical schools completed an online survey. Opportunities and challenges were identified by thematic analyses and subsequently discussed in an international consensus meeting.
Results
Data from 99 CPT teachers from 95 medical schools were analysed. Thirty teachers (30.3%) shared or collaboratively produced digital educational resources. All teachers foresaw opportunities in the more active use of open educational resources, including improving the quality of their teaching. The challenges reported were language barriers, local differences, lack of time, technological issues, difficulties with quality management, and copyright restrictions. Practical solutions for these challenges were discussed and include a peer review system, clear indexing, and use of copyright licenses that permit adaptation of resources.
Conclusion
Key challenges to making greater use of CPT open educational resources are a limited applicability of such resources due to language and local differences and quality concerns. These challenges may be resolved by relatively simple measures, such as allowing adaptation and translation of resources and a peer review system.
000118992 540__ $$9info:eu-repo/semantics/openAccess$$aby$$uhttp://creativecommons.org/licenses/by/3.0/es/
000118992 590__ $$a3.064$$b2021
000118992 591__ $$aPHARMACOLOGY & PHARMACY$$b174 / 279 = 0.624$$c2021$$dQ3$$eT2
000118992 592__ $$a0.732$$b2021
000118992 593__ $$aPharmacology$$c2021$$dQ2
000118992 593__ $$aMedicine (miscellaneous)$$c2021$$dQ2
000118992 594__ $$a4.8$$b2021
000118992 655_4 $$ainfo:eu-repo/semantics/article$$vinfo:eu-repo/semantics/publishedVersion
000118992 700__ $$aRichir, Milan C.
000118992 700__ $$aPapaioannidou, Paraskevi
000118992 700__ $$aLikic, Robert
000118992 700__ $$aSanz, Emilio J.
000118992 700__ $$aChristiaens, Thierry
000118992 700__ $$aCosta, João N.
000118992 700__ $$aMaciulaitis, Romaldas
000118992 700__ $$aDima, Lorena
000118992 700__ $$aColeman, Jamie
000118992 700__ $$aTichelaar, Jelle
000118992 700__ $$avan Agtmael, Michiel A.
000118992 700__ $$aAtanasova, Ivanka
000118992 700__ $$aGaneva, Maria
000118992 700__ $$aGatchev, Emil
000118992 700__ $$aKostadinova, I.I.
000118992 700__ $$aMatanovic, S. Mimica
000118992 700__ $$aVitezic, D.
000118992 700__ $$aWozniak, Greta
000118992 700__ $$aKmonickova, E.
000118992 700__ $$aUrbanek, Karel
000118992 700__ $$aDamkier, P.
000118992 700__ $$aHuupponen, R. K.
000118992 700__ $$aAuffret, Marine
000118992 700__ $$aBejan-Angoulvant, T.
000118992 700__ $$aChouchana, Laurent
000118992 700__ $$aCracowski, Jean-Luc
000118992 700__ $$aDrici, M. D.
000118992 700__ $$aFaillie, J. L.
000118992 700__ $$aGeniaux, Hélène
000118992 700__ $$aMolimard, M.
000118992 700__ $$aOrlikowski, D.
000118992 700__ $$aPalin, Karine
000118992 700__ $$aPers, Y-M
000118992 700__ $$aPicard, Nicolas
000118992 700__ $$aSimon, N.
000118992 700__ $$aToussirot, E.
000118992 700__ $$aBoger, R. H.
000118992 700__ $$aCascorbi, I.
000118992 700__ $$aMueller, S. C.
000118992 700__ $$aRegenthal, R.
000118992 700__ $$aSchwab, M.
000118992 700__ $$aSchwaninger, M. S.
000118992 700__ $$aThuermann, P. A.
000118992 700__ $$aWojnowski, L.
000118992 700__ $$aKouvelas, D.
000118992 700__ $$aRiba, P.
000118992 700__ $$aKerins, David M.
000118992 700__ $$aWilliams, David J.
000118992 700__ $$aCosentino, M.
000118992 700__ $$aDe Ponti, Fabrizio
000118992 700__ $$aFilippelli, Amelia
000118992 700__ $$aLeone, R.
000118992 700__ $$aLocatelli, Vittorio
000118992 700__ $$aJansone, Baiba
000118992 700__ $$aGulbinovic, Romaldas
000118992 700__ $$aMifsud, Janet
000118992 700__ $$aBraszko, Jan J.
000118992 700__ $$aKocic, I.
000118992 700__ $$aBreitenfeld, Luiza
000118992 700__ $$aCastelo-Branco, M.
000118992 700__ $$aConea, Simona
000118992 700__ $$aMagyar, Ioan
000118992 700__ $$aBevc, S.
000118992 700__ $$aKrzan, Mojca
000118992 700__ $$0(orcid)0000-0002-8222-1418$$aBernal, M. L.$$uUniversidad de Zaragoza
000118992 700__ $$aCapellà, D.
000118992 700__ $$aCarcas, A.
000118992 700__ $$aDe Abajo, F. J.
000118992 700__ $$aLopez-Rico, M.
000118992 700__ $$aLucena, M. I.
000118992 700__ $$aPontes, C.
000118992 700__ $$aSanz, E. J.
000118992 700__ $$aBöttiger, Y.
000118992 700__ $$aLe Grevès, Madeleine
000118992 700__ $$ade Waard-Siebinga, I.
000118992 700__ $$aJanssen, Ben J. A.
000118992 700__ $$aKnol, Wilma
000118992 700__ $$aPandit, Rahul
000118992 700__ $$avan Rosse, F.
000118992 700__ $$aDent, G.
000118992 700__ $$aFerro, Albert
000118992 700__ $$aHitchings, A. W.
000118992 700__ $$aKapil, V.
000118992 700__ $$aLinton, K. D.
000118992 700__ $$aLoke, Y. K.
000118992 700__ $$aOkorie, Michael
000118992 700__ $$aPlumb, Richard David
000118992 700__ $$aPontefract, Sarah
000118992 700__ $$aRanmuthu, S.
000118992 700__ $$aSampson, A. P.
000118992 700__ $$aThanacoody, H. K. R.
000118992 700__ $$aWhitfield, Jonathan P.
000118992 700__ $$aWilson, Kurt
000118992 7102_ $$11012$$2315$$aUniversidad de Zaragoza$$bDpto. Farmac.Fisiol.y Med.L.F.$$cÁrea Farmacología
000118992 773__ $$g77, 8 (2021), 1209-1218$$pEur. J. Clin. Pharmacol.$$tEUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY$$x0031-6970
000118992 8564_ $$s975355$$uhttps://zaguan.unizar.es/record/118992/files/texto_completo.pdf$$yVersión publicada
000118992 8564_ $$s2116033$$uhttps://zaguan.unizar.es/record/118992/files/texto_completo.jpg?subformat=icon$$xicon$$yVersión publicada
000118992 909CO $$ooai:zaguan.unizar.es:118992$$particulos$$pdriver
000118992 951__ $$a2023-05-18-16:19:01
000118992 980__ $$aARTICLE